Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
4.050
-0.200 (-4.71%)
At close: Dec 5, 2025, 4:00 PM EST
4.000
-0.050 (-1.23%)
After-hours: Dec 5, 2025, 5:11 PM EST
LIXT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 3.66 | 2.85 | 4.19 | 4.96 | 4.98 | 2.04 | |
| Research & Development | 0.24 | 0.73 | 0.9 | 1.35 | 1.74 | 1.22 | |
| Operating Expenses | 3.9 | 3.57 | 5.09 | 6.31 | 6.72 | 3.27 | |
| Operating Income | -3.9 | -3.57 | -5.09 | -6.31 | -6.72 | -3.27 | |
| Interest Expense | -0.01 | -0.02 | -0.02 | -0.01 | -0.01 | -0 | |
| Interest & Investment Income | 0.01 | 0.01 | 0.02 | 0.01 | 0 | 0 | |
| Currency Exchange Gain (Loss) | 0 | -0 | 0 | -0 | -0 | 0 | |
| Other Non Operating Income (Expenses) | -0.18 | - | - | - | - | - | |
| EBT Excluding Unusual Items | -4.08 | -3.59 | -5.09 | -6.31 | -6.73 | -3.26 | |
| Pretax Income | -4.08 | -3.59 | -5.09 | -6.31 | -6.73 | -3.26 | |
| Net Income | -4.08 | -3.59 | -5.09 | -6.31 | -6.73 | -3.26 | |
| Preferred Dividends & Other Adjustments | 0.05 | - | - | - | - | - | |
| Net Income to Common | -4.13 | -3.59 | -5.09 | -6.31 | -6.73 | -3.26 | |
| Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 1 | 1 | |
| Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 1 | 1 | |
| Shares Change (YoY) | 51.69% | 17.41% | 21.10% | 17.41% | 19.48% | 0.92% | |
| EPS (Basic) | -1.21 | -1.59 | -2.66 | -3.99 | -4.99 | -2.90 | |
| EPS (Diluted) | -1.21 | -1.59 | -2.66 | -3.99 | -4.99 | -2.90 | |
| EBIT | -3.9 | -3.57 | -5.09 | -6.31 | -6.72 | -3.27 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.